Seeing Is Believing
with an average price target of $-5.74. This is a potential upside of $-5.74 (0%) from yesterday's end of day stock price of $0.
Gemini Therapeutics's activity chart (see below) currently has 9 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 40.33 days.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 11-Mar-2022. First documented stock forecast 08-Oct-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$-14.89 (-74.86%)
$20
2 years 8 months 9 days ago
(11-Mar-2022)
1/2 (50%)
$-10 (-66.67%)
33
Buy
$5
$-14.89 (-74.86%)
$5
2 years 8 months 9 days ago
(11-Mar-2022)
1/3 (33.33%)
$-10 (-66.67%)
34
Buy
$10
$-9.89 (-49.72%)
2 years 8 months 17 days ago
(03-Mar-2022)
1/2 (50%)
$-3.4 (-25.37%)
64
Buy
$23
$3.11 (15.64%)
2 years 8 months 20 days ago
(01-Mar-2022)
0/1 (0%)
$10.05 (77.61%)
Hold
$11
$-8.89 (-44.70%)
$11
2 years 8 months 24 days ago
(28-Feb-2022)
0/2 (0%)
$-2.6 (-19.12%)
What is GMTX (Gemini Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GMTX (Gemini Therapeutics) with a proven track record?
Which analyst has the current lower performing score on GMTX (Gemini Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GMTX (Gemini Therapeutics)?
Which analyst is the currently most bullish on GMTX (Gemini Therapeutics)?
Which analyst is the currently most reserved on GMTX (Gemini Therapeutics)?